Literature DB >> 2934288

Immunological studies on Crohn's disease. V. Enumeration of circulating lymphocytes subsets using monoclonal antibodies.

N Okabe, K Fujita, M Yamasaki, T Yao, S Tsuru.   

Abstract

We found normal levels of suppressor cell activity and reduced natural killer (NK) and antibody dependent cell-mediated cytotoxicity (ADCC) activities in patients with Crohn's disease (CD). To further characterize these activities, studies were carried out using monoclonal antibodies. There were no changes in the proportion of OKT4+ (helper/inducer T cells), OKT8+ or Leu 2+ (suppressor/cytotoxic T cells) and Leu 7+ (large granular lymphocytes: LGL, NK + K cells), thereby suggesting that suppressor cell activity in CD is likely to be normal both in function and in number, and that depressed NK and ADCC activities are not due to a reduction in the number of NK or K cells but rather to functional defects. Using a double staining method, we noted a low percentage of both Leu 2 and Leu 7 positive cells in CD.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2934288     DOI: 10.1007/bf02774779

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  26 in total

1.  Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization.

Authors:  C Fiocchi; J R Battisto; R G Farmer
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

2.  Decreased suppressor cell activity in inflammatory bowel disease.

Authors:  H J Hodgson; J R Wands; K J Isselbacher
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

3.  Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.

Authors:  I O Auer; A Röder; J Fröhlich
Journal:  Gastroenterology       Date:  1984-06       Impact factor: 22.682

4.  Comparison in T- and B-cell markers in patients with Sjögren's syndrome and systemic lupus erythematosus.

Authors:  C Morimoto; E L Reinherz; L M Nadler; J A Distaso; A D Steinberg; S F Schlossman
Journal:  Clin Immunol Immunopathol       Date:  1982-02

5.  Impaired natural killer cell activity in patients with inflammatory bowel disease: evidence for a qualitative defect.

Authors:  C H Ginsburg; J T Dambrauskas; K A Ault; Z M Falchuk
Journal:  Gastroenterology       Date:  1983-10       Impact factor: 22.682

6.  Reduced suppressor cell activity in intestinal lymphocytes from patients with Crohn's disease.

Authors:  R L Goodacre; J Bienenstock
Journal:  Gastroenterology       Date:  1982-04       Impact factor: 22.682

7.  Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease.

Authors:  S P James; L M Neckers; A S Graeff; J Cossman; C M Balch; W Strober
Journal:  Gastroenterology       Date:  1984-06       Impact factor: 22.682

8.  T lymphocyte subsets in inflammatory bowel disease: peripheral blood.

Authors:  W S Selby; D P Jewell
Journal:  Gut       Date:  1983-02       Impact factor: 23.059

9.  Immunological studies on Crohn's disease. IV. Decreased ADCC activity.

Authors:  N Okabe; K Fujita; K Takenaka; T Yao
Journal:  J Clin Lab Immunol       Date:  1986-02

10.  Suppressor cell function of human granular lymphocytes identified by the HNK-1 (Leu 7) monoclonal antibody.

Authors:  A B Tilden; T Abo; C M Balch
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

View more
  1 in total

1.  An HLA study on 149 Japanese patients with Crohn's disease.

Authors:  H Matake; N Okabe; S Naito; T Yao
Journal:  Gastroenterol Jpn       Date:  1992-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.